Divergent diagnosis from arthroscopic findings and identification of CPII and C2C for detection of cartilage degradation in horses.

The study investigates the changes in the concentrations of molecules indicative of joint cartilage damage and repair in horses with specific joint conditions, and it analyses how these concentrations relate to observable joint damage. The research finding suggests that more understanding is required for accurate use of these molecules as diagnostic tools.

Objective and Overview of the Study

• The study aimed to examine the potential of using certain biological markers (biomarkers), namely collagen type II cleavage site (C2C) and procollagen II C-propeptide (CPII) in the synovial fluid, for diagnosing joint cartilage damage in horses. These markers indicate cartilage degradation (C2C) and synthesis (CPII) respectively.
• The researchers investigated this potential in horses with two specific joint conditions – intraarticular fractures and osteochondrosis dissecans (OCD), a disorder in which fragments of bone and cartilage dislodge from the joint surface.
• They also explored how these biomarker levels related to the damage observed through an arthroscopic examination – a diagnostic tool that involves looking into the joint with a small camera.

Methods and Procedures

• Synovial fluid samples were collected from a total of 36 joints in 18 horses with either intraarticular fractures or OCD.
• When available, samples were taken from the unaffected opposing joints for use as a control group.
• Concentration levels of C2C and CPII within these samples were determined using enzyme-linked immunosorbant assays (ELISA) – a common laboratory technique for detecting and measuring specific proteins.
• The severity of cartilage damage in the horses was also graded through arthroscopic examination, and the researchers investigated the correlation between these severity scores and the biomarker levels.

Key Findings

• The concentration of C2C was found to be increased in OCD-affected joints but not in fracture-affected joints, indicating higher cartilage degradation in the former. Conversely, the concentration of CPII was found increased in fracture-affected joints, indicating higher cartilage synthesis.
• However, the study found no correlation between the levels of these biomarkers and the severity of joint damage as assessed by arthroscopic examination. Therefore, the researchers conclude that further knowledge and understanding is required for accurate utilization of C2C and CPII as diagnostic markers.